XBKS News Alert Xenith Bankshares (XBKS) 6.45 12/25/2014 16:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Xenith Bankshares (XBKS) 6.45 $XBKS

Xenith Bankshares EPS of $0.05
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 4:53PM CST

XBKS: 6.45 (+0.05)

Xenith Bankshares, Inc. Reports 2014 Third Quarter Results, Strong Loan and Deposit Growth
GlobeNewswire - Tue Nov 04, 4:02PM CST
Xenith Bankshares, Inc. (Nasdaq:XBKS), parent company of Xenith Bank, a business-focused bank serving the Greater Washington, D.C., Richmond, and Greater Hampton Roads, Virginia markets, today announced financial results for the three and nine months ended September 30, 2014.
XBKS: 6.45 (+0.05)

Xenith Bankshares, Inc. Announces Senior Term Loan Credit Facility and Private Placement of Common Equity
GlobeNewswire - Tue Sep 30, 3:15PM CDT
Xenith Bankshares, Inc. (Nasdaq:XBKS), parent company of Xenith Bank, today announced the signing of a senior term loan credit agreement with a national bank providing for a senior unsecured term loan credit facility up to $15 million under which the company initially has borrowed $12 million. An additional $3 million is available for a one-year period under a delayed draw term loan commitment. The company also announced the issuance and sale in a private placement to two investors of an aggregate of 880,000 shares of the company's common stock for $6.35 per share, resulting in total proceeds to the company of nearly $5.6 million. A substantial portion of the net proceeds from this senior term loan and private placement will be contributed to Xenith Bank to fund organic loan growth, continued investment in infrastructure and personnel, and for other general corporate purposes.
XBKS: 6.45 (+0.05)

Xenith Bankshares, Inc. Reports Second Quarter and First Half 2014 Results, Loan Growth of 24%
GlobeNewswire - Wed Aug 06, 5:12PM CDT
Xenith Bankshares, Inc. (Nasdaq:XBKS), parent company of Xenith Bank, a business-focused bank serving the Greater Washington, D.C., Richmond and Greater Hampton Roads, Virginia markets, today announced financial results for the three and six months ended June 30, 2014.
XBKS: 6.45 (+0.05)

Xenith Bankshares, Inc. Announces Completion of Colonial Virginia Bank Acquisition
GlobeNewswire - Tue Jul 01, 7:11AM CDT
Xenith Bankshares, Inc. (Nasdaq:XBKS), parent company of Xenith Bank, today announced the completion of its acquisition of Colonial Virginia Bank ("CVB" , whereby CVB was merged with and into Xenith Bank. Xenith Bank will continue to operate CVB's two full-service banking offices in Gloucester, Virginia, and one loan production office in Yorktown, Virginia. Today, all CVB customers become customers of Xenith Bank; however, the CVB branches will continue to operate under the name Colonial Virginia Bank for an undetermined period of time.
XBKS: 6.45 (+0.05)

Global and Chinese Single-Mode Optical Fiber Industry Report 2014
M2 - Thu Feb 27, 2:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/s6rsh3/global_and) has announced the addition of the "Global and Chinese Single-Mode Optical Fiber Industry Report 2014" report to their offering. The Global and Chinese Single-Mode Optical Fiber Industry Report 2014 is a professional and in-depth study on the current state of the global single-mode optical fiber industry with a focus on the Chinese situation. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. Single-mode optical fiber market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Single-mode optical fiber industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. A key feature of the report is its focus on 14 industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. Single-mode optical fiber industry development proposals and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: Chapter One Single-Mode Optical Fiber Industry Overview Chapter Two Single-mode Optical Fiber International and China Market Analysis Chapter Three Single-mode Optical Fiber Development Environmental Analysis Chapter Four Single-mode Optical Fiber Development Policy and Plan Chapter Five Single-mode Optical Fiber Manufacturing Process and Cost Structure Chapter Six 2009-2014 Single-mode Optical Fiber Productions Supply Sales Demand Market Status and Forecast Chapter Seven Single-mode Optical Fiber Key Manufacturers Analysis Chapter Eight Up and Down Stream Industry Analysis Chapter Nine Single-mode Optical Fiber Marketing Channels Analysis Chapter Ten 2014-2018 Single-mode Optical Fiber Productions Supply Sales Demand Market Status and Forecast Chapter Eleven Single-mode Optical Fiber Industry Development Proposals Chapter Twelve Single-mode Optical Fiber New Project Investment Feasibility Analysis Chapter Thirteen Global and China Single-mode Optical Fiber Industry Research Conclusions Companies Mentioned - Alcatel-Lucent - Corning - Fasten Fiber optics Co., Ltd (FPC) - Fiber Home Technologies Group - Fujikura - Furukawa Electric - Futong Group - Hengtong Optic-electric Co., Ltd. - Pirelli - Shenzhen Tefa Touchplus Information Corp - Sumitomo Electric - Tongding Group - Yangtze Optical Fibre and Cable Company Ltd. (YOFC) For more information visit http://www.researchandmarkets.com/research/s6rsh3/global_and
XBKS: 6.45 (+0.05), ALU: 3.67 (+0.03)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 255

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 176

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 59

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading